Director Simanovsky Michael bought $897,835 worth of shares (42,111 units at $21.32) (SEC Form 4)
$SNDA
Hospital/Nursing Management
Health Care
| FORM 4 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934 or Section 30(h) of the Investment Company Act of 1940 |
|
|||||||||||||||
| Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b). | |||||||||||||||||
| Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10. | |||||||||||||||||
1. Name and Address of Reporting Person*
(Street)
|
2. Issuer Name and Ticker or Trading Symbol
SONIDA SENIOR LIVING, INC. [ SNDA ] |
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
|
||||||||||||||||||||||||
|
3. Date of Earliest Transaction
(Month/Day/Year) 01/08/2025 | ||||||||||||||||||||||||||
|
4. If Amendment, Date of Original Filed
(Month/Day/Year) |
6. Individual or Joint/Group Filing (Check Applicable Line)
|
| Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|
| 1. Title of Security (Instr. 3) | 2. Transaction Date (Month/Day/Year) | 2A. Deemed Execution Date, if any (Month/Day/Year) | 3. Transaction Code (Instr. 8) | 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) | 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) | 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) | 7. Nature of Indirect Beneficial Ownership (Instr. 4) | |||
| Code | V | Amount | (A) or (D) | Price | ||||||
| Common Stock | 01/08/2025 | P | 15,000 | A | $21.34 | 1,580,481 | I | See footnotes(1)(2)(3) | ||
| Common Stock | 01/10/2025 | P | 27,111 | A | $21.31 | 1,607,592 | I | See footnotes(1)(2)(3) | ||
| Common Stock | 709,744 | I | See footnotes(1)(4)(5) | |||||||
| Common Stock | 648,942 | I | See footnotes(1)(5)(6) | |||||||
| Common Stock | 5,266,159 | I | See footnotes(1)(5)(7) | |||||||
| Common Stock | 1,032,216 | I | See footnotes(1)(5)(8) | |||||||
|
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities) | |||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1. Title of Derivative Security (Instr. 3) | 2. Conversion or Exercise Price of Derivative Security | 3. Transaction Date (Month/Day/Year) | 3A. Deemed Execution Date, if any (Month/Day/Year) | 4. Transaction Code (Instr. 8) | 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) | 6. Date Exercisable and Expiration Date (Month/Day/Year) | 7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) | 8. Price of Derivative Security (Instr. 5) | 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) | 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) | 11. Nature of Indirect Beneficial Ownership (Instr. 4) | ||||
| Code | V | (A) | (D) | Date Exercisable | Expiration Date | Title | Amount or Number of Shares | ||||||||
1. Name and Address of Reporting Person*
(Street)
Relationship of Reporting Person(s) to Issuer
| ||||||||||||||||||||||||
1. Name and Address of Reporting Person*
(Street)
Relationship of Reporting Person(s) to Issuer
| ||||||||||||||||||||||||
1. Name and Address of Reporting Person*
(Street)
Relationship of Reporting Person(s) to Issuer
| ||||||||||||||||||||||||
1. Name and Address of Reporting Person*
(Street)
Relationship of Reporting Person(s) to Issuer
| ||||||||||||||||||||||||
1. Name and Address of Reporting Person*
(Street)
Relationship of Reporting Person(s) to Issuer
| ||||||||||||||||||||||||
1. Name and Address of Reporting Person*
(Street)
Relationship of Reporting Person(s) to Issuer
| ||||||||||||||||||||||||
1. Name and Address of Reporting Person*
(Street)
Relationship of Reporting Person(s) to Issuer
| ||||||||||||||||||||||||
1. Name and Address of Reporting Person*
(Street)
Relationship of Reporting Person(s) to Issuer
| ||||||||||||||||||||||||
1. Name and Address of Reporting Person*
(Street)
Relationship of Reporting Person(s) to Issuer
|
| Explanation of Responses: |
| 1. This Form 4 is being filed jointly by Michael Simanovsky, a United States citizen; Conversant Capital LLC, a Delaware limited liability company ("Conversant Capital"); Conversant GP Holdings LLC, a Delaware limited liability company ("Conversant GP"); Conversant Private GP LLC, a Delaware limited liability company ("Conversant Private GP"); Conversant Dallas Parkway (A) LP, a Delaware limited partnership ("Investor A"); Conversant Dallas Parkway (B) LP, a Delaware limited partnership ("Investor B"); Conversant Dallas Parkway (D) LP, a Delaware limited partnership ("Investor D"); Conversant PIF Aggregator A LP, a Delaware limited partnership ("Aggregator A") and Conversant Dallas Parkway (F) LP, a Delaware limited partnership ("Investor F") (collectively the filing persons are the "Reporting Persons"). |
| 2. Shares are held by Aggregator A. |
| 3. Conversant Private GP is the general partner of Aggregator A and Conversant Capital is the investment manager to Aggregator A. Mr. Simanovsky is the managing member of Conversant Capital and Conversant Private GP. By virtue of these relationships, each of Mr. Simanovsky, Conversant Capital and Conversant Private GP may be deemed a beneficial owner of the securities held by Aggregator A. Mr. Simanovsky, Conversant Capital, and Conversant Private GP each disclaims beneficial ownership of the securities held by Aggregator A except to the extent of his or its pecuniary interest therein. |
| 4. Shares are held by Investor B. |
| 5. Conversant GP is the general partner of each of Investor A, Investor B, Investor D and Investor F. Conversant Capital is the investment manager to each of Investor A, Investor B, Investor D and Investor F. Mr. Simanovsky is the managing member of Conversant Capital and Conversant GP. By virtue of these relationships, each of Mr. Simanovsky, Conversant Capital and Conversant GP may be deemed a beneficial owner of the securities held by each of Investor A, Investor B, Investor D and Investor F. Mr. Simanovsky, Conversant Capital, and Conversant GP each disclaims beneficial ownership of the securities held by Investor A, Investor B, Investor D and Investor F except to the extent of his or its pecuniary interest therein. |
| 6. Shares are held by Investor F. |
| 7. Shares are held by Investor A. |
| 8. Shares are held by Investor D. |
| Remarks: |
| Robert T. Grove, a Principal of Conversant Capital, serves as a member of the Issuer's board of directors. On the basis of the relationships between Mr. Grove and the Reporting Persons, the Reporting Persons may be considered a director of the Issuer for purposes of Section 16 of the Securities Exchange Act of 1934, as amended. |
| MICHAEL J. SIMANOVSKY, By: /s/ Paul Dumaine, Attorney-in-fact for Michael J. Simanovsky | 01/13/2025 | |
| CONVERSANT CAPITAL LLC , By: /s/ Paul Dumaine, General Counsel and Chief Compliance Officer | 01/13/2025 | |
| CONVERSANT DALLAS PARKWAY (A) LP, By: Conversant GP Holdings LLC, its general partner, By: /s/ Paul Dumaine, General Counsel and Chief Compliance Officer | 01/13/2025 | |
| CONVERSANT DALLAS PARKWAY (B) LP, By: Conversant GP Holdings LLC, its general partner, by: /s/ Paul Dumaine, General Counsel and Chief Compliance Officer | 01/13/2025 | |
| CONVERSANT DALLAS PARKWAY (D) LP By: Conversant GP Holdings LLC, its general partner By: /s/ Paul Dumaine, General Counsel and Chief Compliance Officer | 01/13/2025 | |
| CONVERSANT PRIVATE GP LLC, By: /s/ Paul Dumaine, General Counsel and Chief Compliance Officer | 01/13/2025 | |
| CONVERSANT PIF AGGREGATOR A LP By: Conversant Private GP LLC, its general partner, By: /s/ Paul Dumaine, General Counsel and Chief Compliance Officer | 01/13/2025 | |
| CONVERSANT DALLAS PARKWAY (F) LP By: Conversant GP Holdings LLC, its general partner, /s/ By: Paul Dumaine, General Counsel and Chief Compliance Officer | 01/13/2025 | |
| CONVERSANT GP HOLDINGS LLC, By: /s/ Paul Dumaine, General Counsel and Chief Compliance Officer | 01/13/2025 | |
| ** Signature of Reporting Person | Date | |
| Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly. | ||
| * If the form is filed by more than one reporting person, see Instruction 4 (b)(v). | ||
| ** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a). | ||
| Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure. | ||
| Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number. | ||